/

AtriCure, Inc.

ATRC US

ATRC USAtriCure, Inc.

United States Composite

22.24

USD

-2.58

(-10.39%)

-0.66EPS Dil.

-33.84P/E

1.06BMarket Cap

Next Earnings

April 30

Held by Insiders

3.08%

Held by Institutions

102.26%

Short % of Float

4.99%

YTD Yield

-47.27%

3Y Yield

-69.94%

5Y Yield

-22.97%

Capital Structure

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'23

ST Debt

LT Borrowings

LT Finance Leases

Preferred Equity and Hybrid Capital

- -

Shares Outstanding

Market Capitalization

2,337

2,076

1,696

Working Capital

FRC

•

in mil. unless spec.

Jun'23

Sep'23

Dec'23

Total Current Assets

238

253

266

Cash, Cash Equivalents & STI

127

133

137

Accounts Receivable, Net

Inventories

Total Current Liabilities

Payables & Accruals

ST Debt

Deferred Revenue

- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years

5 years

1 year

Sales/Revenue/Turnover

17.72%

15.54%

20.91%

Net Income, GAAP

-56.12%

-93.04%

34.78%

Free Cash Flow

-41.97%

-45.04%

2.56%

Total Cash Common Dividend

- -

Total Equity

24.30%

15.97%

1.97%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

2021

274

2022

330

2023

101

107

399

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

2021

-0.38

-0.36

2.15

-0.30

1.11

2022

-0.33

-0.32

-0.27

-0.09

-1.02

2023

-0.14

-0.11

-0.20

-0.21

-0.66

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

2021

- -

2022

- -

2023

- -

Company Description

CEO: Mr. Michael H. Carrel
Full Time Employees: 1,200
Sector: Healthcare
Industry: Medical Instruments & Supplies
Address: 7555 Innovation Way Mason OH United States 45040
IPO Date: Aug 5, 2005
Website: www.atricure.com
Business: AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Company News

CNBC
10 days ago
Here are Tuesday's biggest analyst calls: Nvidia, Tesla, Apple, Roblox, Tesla, Qualcomm, Disney & more
Zacks
13 days ago
AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management
Yahoo
15 days ago
AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management
Yahoo
23 days ago
AtriCure to Announce First Quarter 2024 Financial Results
Tipranks
23 days ago
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and Sight Sciences (SGHT)
Yahoo
a month ago
AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Yahoo
a month ago
AtriCure (ATRC) Declined due to Concerns Over Anti-Obesity Drug
Yahoo
2 months ago
Chief Legal Officer Karl Dahlquist Sells 8,231 Shares of AtriCure Inc (ATRC)

Company Description

CEO: Mr. Michael H. Carrel
Full Time Employees: 1,200
Sector: Healthcare
Industry: Medical Instruments & Supplies
Address: 7555 Innovation Way Mason OH United States 45040
IPO Date: Aug 5, 2005
Website: www.atricure.com
Business: AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Company News

CNBC
10 days ago
Here are Tuesday's biggest analyst calls: Nvidia, Tesla, Apple, Roblox, Tesla, Qualcomm, Disney & more
Zacks
13 days ago
AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management
Yahoo
15 days ago
AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management
Yahoo
23 days ago
AtriCure to Announce First Quarter 2024 Financial Results
Tipranks
23 days ago
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and Sight Sciences (SGHT)
Yahoo
a month ago
AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Yahoo
a month ago
AtriCure (ATRC) Declined due to Concerns Over Anti-Obesity Drug
Yahoo
2 months ago
Chief Legal Officer Karl Dahlquist Sells 8,231 Shares of AtriCure Inc (ATRC)